Biogen’s Chief Medical Officer calls the results “a shot in the arm.” An analyst calls the noise “deafening.” A doctor sees potential help for patients.
Category: NASDAQ:BIIB
Biogen And Eisai Present Positive Results For Experimental Alzheimer’s Drug
Drugmakers Eisai and Biogen presented positive results of their much-anticipated experimental Alzheimer’s drug BAN-2401 today at the Alzheimer’s Association International Conference in Chicago. But doctors still have questions.
Biogen And Eisai Say Alzheimer’s Drug A Success, Reversing Earlier Result
A complicated new clinical trial could give some hope to Alzheimer’s patients and investors in drug companies. But there are lots of devilish details.
